Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001683168-23-008419
Filing Date
2023-11-22
Accepted
2023-11-22 16:00:15
Documents
1
Group Members
PHARMACYTE BIOTECH, INC.

Document Format Files

Seq Description Document Type Size
1 FORM SC-13D pharmacyte_sc13d.htm SC 13D 58501
  Complete submission text file 0001683168-23-008419.txt   60343
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filed by) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: SC 13D
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3950 JOHNS CREEK COURT SUITE 100 SUWANEE GA 30024
Business Address 3950 JOHNS CREEK COURT SUITE 100 SUWANEE GA 30024 770-500-3910
FEMASYS INC (Subject) CIK: 0001339005 (see all company filings)

EIN.: 113713499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94233 | Film No.: 231433322
SIC: 3841 Surgical & Medical Instruments & Apparatus